Dr. Urs A. MEYER University of Basel
CV
| Urs A. Meyer is Professor of Pharmacology and Chairman of the Division of Pharmacology/Neurobiology at the Biozentrum of the University of Basel and its Medical School, Basel, Switzerland. He also is a consultant physician in the Outpatient Clinic of the Department of Medicine of the University Hospital in Basel. Urs A. Meyer received his M.D. degree from the University of Zürich in 1967 and subsequently was an intern and resident in internal medicine at the University of California, San Francisco. From 1969 to 1971 he was a postdoctoral fellow in Clinical Pharmacology and Hepatology and from 1972 to 1975 an assistant professor in clinical pharmacology at the University of California, San Francisco. Urs A. Meyer then returned to Switzerland as Chief of the Division of Clinical Pharmacology of the University of Zürich Medical School and in 1983 was appointed to his present position as Professor and Chairman at the University of Basel. Research interests have included the study of genetic and environmental factors that determine individual drug response with special emphasis on pharmacogenetic conditions. In particular, Urs A. Meyer has studied experimental and clinical porphyrias and has used a large human liver bank to predict drug metabolism patterns of new drugs and to study the molecular mechanisms of environmental and genetic factors influencing drug metabolizing enzymes. His laboratory has been involved in the cloning and characterization of numerous human genes controlling drug-metabolizing enzymes, i.e. microsomal epoxide hydrolase, several cytochromes P450 (CYP2D6, 2C9, 2C19), N-acetyltransferases, and has elucidated several genetic polymorphisms of human drug response at the molecular level. More recently, his laboratory has made major contributions to the molecular events that lead to induction of drug metabolism. The contributions of Urs A. Meyer are recognized in the ISI Highly Cited Researcher Database (isihighlycited.com). |
Mitgliedschaften
| The American Society for Pharmacology and Experimental Therapeutics | |
| Union Schweizerischer Gesellschaften für Experimentelle Biologie (USGEB) | |
| Drug Metabolism Section, IUPHAR | |
| International Society for the Study of Xenobiotics (ISSX) | |
| American Association for the Study of Liver Diseases (AASLD) | |
| Gesellschaft für Fortschritte in der Inneren Medizin (Ludwig-Heilmeyer-Gesellschaft) |
Publikationen
| Induction of Drug Metabolism: the role of nuclear receptors, 2003 | |
| Pharmacogenetics - five decades of therapeutic lessons from genetic diversity, 2004 | |
| Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha, 2005 | |
| Pharmacogenomics, 2005 |
Auszeichnungen
| Cloetta-Award 1974 for Medical Research, 1974 | |
| Rawls-Palmer Award for Progress in Medicine (with Frank J. Gonzalez), American Society for Clinical Pharmacology and Therapeutics, 1991 | |
| Robert Pfleger-Forschungspreis 2004 | |
| RT Williams Distinguished Scientific Achievement Award "International Society for the Study of Xenobiotics" ISSX in Bethesda, MD, USA, 2004 |
